Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | ESC Heart Failure |
| Online Access: | https://doi.org/10.1002/ehf2.15262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849316414107680768 |
|---|---|
| author | Roberto Pecoits‐Filho Michelle M.Y. Wong Monica Moorthy Debasish Banerjee Suman Behera Viviane Calice‐Silva Mogamat‐Yazied Chothia Gates B. Colbert Martha Gulati Charles A. Herzog Fadi Jouhra Edgar V. Lerma Charu Malik Kershaw V. Patel Amina Rakisheva Giuseppe M.C. Rosano Priyanka Satish Henry H.L. Wu Angela Yee‐Moon Wang |
| author_facet | Roberto Pecoits‐Filho Michelle M.Y. Wong Monica Moorthy Debasish Banerjee Suman Behera Viviane Calice‐Silva Mogamat‐Yazied Chothia Gates B. Colbert Martha Gulati Charles A. Herzog Fadi Jouhra Edgar V. Lerma Charu Malik Kershaw V. Patel Amina Rakisheva Giuseppe M.C. Rosano Priyanka Satish Henry H.L. Wu Angela Yee‐Moon Wang |
| author_sort | Roberto Pecoits‐Filho |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9b03f98e8cbc479e986681716d2b2191 |
| institution | Kabale University |
| issn | 2055-5822 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj-art-9b03f98e8cbc479e986681716d2b21912025-08-20T03:51:44ZengWileyESC Heart Failure2055-58222025-08-011242597260410.1002/ehf2.15262Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney communityRoberto Pecoits‐Filho0Michelle M.Y. Wong1Monica Moorthy2Debasish Banerjee3Suman Behera4Viviane Calice‐Silva5Mogamat‐Yazied Chothia6Gates B. Colbert7Martha Gulati8Charles A. Herzog9Fadi Jouhra10Edgar V. Lerma11Charu Malik12Kershaw V. Patel13Amina Rakisheva14Giuseppe M.C. Rosano15Priyanka Satish16Henry H.L. Wu17Angela Yee‐Moon Wang18Arbor Research Collaborative for Health Ann Arbor Michigan USADivision of Nephrology, Department of Medicine University of British Columbia Vancouver British Columbia CanadaInternational Society of Nephrology Brussels BelgiumRenal and Transplantation Unit, St George's University Hospitals NHS Foundation Trust, Molecular and Clinical Sciences Research Institute St George's University of London London UKDivision of Nephrology, Southlake Regional Health And Michael G. DeGroote School of Medicine McMaster UniversityResearch Department, Pro‐rim Foundation and School of Medicine UNIVILLE Joinville SC BrazilDivision of Nephrology, Department of Medicine Stellenbosch University Cape Town South AfricaDepartment of Nephrology Texas A&M College of Medicine Dallas Texas USABarbra Streisand Women's Heart Center, Department of Cardiology Cedars Sinai Heart Institute Los Angeles California USACardiology Division, Dept. of Medicine Hennepin Healthcare/University of Minnesota Minneapolis Minnesota USACardiology Department, St George's University Hospitals NHS Foundation Trust, Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute St George's University of London London UKUniversity of Illinois at Chicago/Advocate Christ Medical Center Oak Lawn Illinois USAInternational Society of Nephrology Brussels BelgiumCenter for Cardiovascular Prevention, Ascension Texas Cardiovascular Dell School of Medicine Austin Texas USACardiology Department Scientific Research Institute of Cardiology and Internal Medicine Almaty KazakhstanCentre for Clinical and Basic Research, IRCCS San Raffaele Rome ItalyCenter for Cardiovascular Prevention, Ascension Texas Cardiovascular Dell School of Medicine Austin Texas USARenal Research, Kolling Institute of Medical Research Royal North Shore Hospital & The University of Sydney Sydney AustraliaDepartment of Renal Medicine, Singapore General Hospital Duke‐National University of Singapore (NUS) Academic Medical Center Singaporehttps://doi.org/10.1002/ehf2.15262 |
| spellingShingle | Roberto Pecoits‐Filho Michelle M.Y. Wong Monica Moorthy Debasish Banerjee Suman Behera Viviane Calice‐Silva Mogamat‐Yazied Chothia Gates B. Colbert Martha Gulati Charles A. Herzog Fadi Jouhra Edgar V. Lerma Charu Malik Kershaw V. Patel Amina Rakisheva Giuseppe M.C. Rosano Priyanka Satish Henry H.L. Wu Angela Yee‐Moon Wang Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community ESC Heart Failure |
| title | Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community |
| title_full | Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community |
| title_fullStr | Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community |
| title_full_unstemmed | Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community |
| title_short | Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community |
| title_sort | optimization of renin angiotensin aldosterone inhibitor therapies for evidence based indications a call to action from the cardio kidney community |
| url | https://doi.org/10.1002/ehf2.15262 |
| work_keys_str_mv | AT robertopecoitsfilho optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT michellemywong optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT monicamoorthy optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT debasishbanerjee optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT sumanbehera optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT vivianecalicesilva optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT mogamatyaziedchothia optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT gatesbcolbert optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT marthagulati optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT charlesaherzog optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT fadijouhra optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT edgarvlerma optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT charumalik optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT kershawvpatel optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT aminarakisheva optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT giuseppemcrosano optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT priyankasatish optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT henryhlwu optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity AT angelayeemoonwang optimizationofreninangiotensinaldosteroneinhibitortherapiesforevidencebasedindicationsacalltoactionfromthecardiokidneycommunity |